Everything below concerns Redox cofactor. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-08-01. Where a claim depends on a specific study, the study is described rather than over-claimed.
Solid NAD+ is usually supplied as a white to off-white powder or lyophilized preparation. It is hygroscopic and should be kept desiccated at low temperature, commonly -20 °C or below for long-term storage. Aqueous solutions are less stable than dry material and are often prepared fresh or stored frozen in aliquots. Light exposure and repeated freeze-thaw cycles can promote degradation, so amber containers and single-use aliquots are preferred. Buffered solutions near neutral pH are generally less stable than acidic or frozen preparations.
Quantification of NAD+ in biological samples typically uses liquid chromatography coupled to mass spectrometry. Enzymatic cycling assays offer higher throughput and rely on NAD+ dependent dehydrogenases to amplify signal. Both approaches require careful sample quenching because NAD+ can be rapidly consumed or converted after collection. Acidic extraction is common for NAD+, while alkaline conditions favor NADH in some protocols. Isotopically labeled internal standards help correct for losses during extraction and ionization.
In glycolysis, the tricarboxylic acid cycle, and fatty acid oxidation, NAD+ is reduced to NADH at specific dehydrogenase steps. NADH then delivers electrons to the mitochondrial electron transport chain, mainly at complex I, supporting oxidative phosphorylation and ATP production. The balance between NAD+ and NADH, often expressed as a ratio, influences metabolic flux and redox homeostasis in different cellular compartments. Cytosolic and mitochondrial pools are connected but not identical, and their ratios can differ substantially because of compartment-specific enzymes and transport systems.
Beyond redox chemistry, NAD+ serves as a substrate for enzymes that cleave the molecule and transfer its ADP-ribose moiety or remove acetyl groups. Sirtuins consume NAD+ during deacetylation, poly(ADP-ribose) polymerases use it in DNA damage responses, and CD38 enzymes hydrolyze it to signaling metabolites. These consumption pathways mean that NAD+ availability can influence gene regulation, DNA repair, and calcium signaling. Cellular NAD+ concentrations decline in some tissues with age in animal models, but whether this decline is a cause or consequence of aging in humans remains an active open question.
Nicotinamide adenine dinucleotide, commonly abbreviated NAD+, is a dinucleotide coenzyme built from an adenine nucleotide and a nicotinamide nucleotide joined by a pyrophosphate linkage. Its oxidized form carries a positive charge on the nicotinamide ring, while the reduced form, NADH, carries a hydride equivalent. The molecule participates in hundreds of oxidoreductase reactions, where it accepts or donates electrons and protons. Because it can cycle between oxidized and reduced states without net consumption, NAD+ functions as a reusable electron carrier rather than a fuel molecule.
| Property | Value | Notes |
|---|---|---|
| Solubility | Freely soluble in water | Forms acidic solution; salt form may alter solubility |
| Typical storage temperature | -20 °C or lower | Desiccated and protected from light |
| Common analytical method | LC-MS | Used for biological quantification |
| UV absorbance maximum | 260 nm | Aqueous solution; pH dependent |
| Common synonym | Diphosphopyridine nucleotide | Older name abbreviated DPN |
Quality control for NAD+ materials typically combines identity, purity, and water content checks. Identity may be confirmed by ultraviolet spectrum, retention time in chromatography, or mass accuracy, while purity is assessed by HPLC peak area or quantitative nuclear magnetic resonance. Residual water and solvents can affect molar calculations and enzyme assays, so Karl Fischer titration or thermogravimetric analysis may be used. Commercial materials vary in grade and counterion form, and published methods should specify the exact salt or hydrate when reporting concentrations. Regulatory status depends on intended use, with research reagents, dietary ingredients, and clinical products treated under different frameworks.
Quantification of NAD+ in biological samples usually relies on separation techniques coupled to sensitive detection. High-performance liquid chromatography with ultraviolet detection can measure the oxidized form by its absorbance near 260 nm, while mass spectrometry provides greater specificity and can distinguish NAD+ from close analogs. Enzymatic cycling assays use coupled dehydrogenase reactions to amplify signal and estimate NAD+ concentrations in cell or tissue extracts. Because NAD+ and NADH interconvert rapidly, sample preparation must quench metabolism quickly and preserve the redox state before analysis.
The stability of NAD+ depends on pH, temperature, light exposure, and the presence of degradative enzymes. Aqueous solutions are generally more stable under mildly acidic to neutral conditions and degrade faster under alkaline conditions or prolonged heat. The solid is hygroscopic and should be stored desiccated, often frozen, and protected from repeated freeze-thaw cycles. In laboratory handling, aliquots reduce repeated temperature changes, and chelating agents may limit metal-catalyzed hydrolysis in some buffers. These practices matter because even small amounts of NADH or hydrolysis products can interfere with quantitative assays.
The nicotinamide ring undergoes reversible reduction at the para position, converting NAD+ to NADH. This reaction transfers a hydride equivalent, not a free hydrogen atom or electron alone. Because the redox pair has a defined reduction potential, it links oxidation of fuels to respiratory chain activity. Many dehydrogenases use NAD+ as a co-substrate and produce NADH. The ratio of NAD+ to NADH reflects metabolic state and influences flux through several pathways.
NAD+ also serves as a substrate for enzymes that cleave it, including sirtuins, PARPs, and CD38. These enzymes consume NAD+ and release nicotinamide and ADP-ribose or related products. The dual roles as redox cofactor and signaling substrate connect NAD+ to DNA repair, circadian regulation, and calcium signaling. Cellular NAD+ concentrations vary by tissue, time of day, and stress exposure. How these consumption pathways interact with redox balance remains an active area of research.
Commercial NAD+ is supplied as a solid, often as the free acid or a salt, and purity is verified by chromatographic methods. Laboratories typically store it desiccated at minus 20 degrees Celsius or below. Working solutions are prepared fresh because even sterile aqueous solutions can lose activity over hours to days depending on pH and temperature. Documentation may include a certificate of analysis, an assay value, and a recommended retest date. Researchers should verify identity and purity when results depend on precise cofactor concentrations.
NAD+ is commonly measured by high-performance liquid chromatography with ultraviolet detection, often at 254 or 260 nm. Enzymatic cycling assays provide higher sensitivity by coupling NAD+ to a reporter reaction. Mass spectrometry can distinguish NAD+ from close analogues and confirm isotope labeling. Sample preparation usually involves rapid quenching of metabolism to prevent interconversion with NADH. Because NAD+ and NADH differ by one hydride, extraction conditions strongly affect the measured ratio.
Cells produce NAD+ through several biosynthetic routes. The salvage pathway recycles nicotinamide, while the Preiss-Handler pathway uses nicotinic acid, and a de novo route can start from tryptophan in some organisms. In mammals, the salvage pathway is generally considered the main source under ordinary conditions. Tissue concentrations vary widely by cell type and compartment, and measured declines with age have been reported in some studies. Whether such changes drive aging or mainly accompany it remains an open question.
Nicotinamide adenine dinucleotide, commonly abbreviated NAD+, is a coenzyme present in all living cells. The molecule consists of two nucleotides linked by phosphate groups, with adenine and a nicotinamide ring as its principal features. In its oxidized form, the nicotinamide ring can accept a hydride ion, becoming NADH. This reversible conversion places NAD+ at the center of many electron-transfer reactions. Its role as a redox carrier is well established across bacteria, plants, fungi, and animals.
=== EC 1.1.5 With a quinone or similar compound as acceptor === EC 1.1.5.1: deleted, see EC 1.1.99.18 cellobiose dehydrogenase (acceptor) EC 1.1.5.2: quinoprotein glucose dehydrogenase EC 1.1.5.3: glycerol-3-phosphate dehydrogenase (quinone) EC 1.1.5.4: malate dehydrogenase (quinone) EC 1.1.5.5: alcohol dehydrogenase (quinone) EC 1.1.5.6: formate dehydrogenase-N EC 1.1.5.7: cyclic alcohol dehydrogenase (quinone) EC 1.1.5.8: quinate dehydrogenase (quinone)
The shape of the ends of the bones — Some joints normally have a large range of movement, such as the shoulder and hip. Both are ball-and-socket joints. The joint ends of bones finish their growth last, so children tend to have more flexible joints than adults; children may "grow out of" hypermobility as their bone ends fully develop. A shallow socket will lead to a relatively large range of movement. If the hip socket is particularly shallow, then the hip may dislocate easily. Ligament problems— Ligaments are made of several types of protein fiber, including elastin and collagen. Gymnasts and athletes can voluntarily acquire hypermobility in some joints by stretching healthy ligaments over time. However, weak or abnormally long ligaments can cause unstable hypermobile joints. Protein deficiencies may weaken ligaments. Some hormones may alter the structure of collagen proteins. For example, in late pregnancy, relaxin allows the ligaments of the pelvis to lengthen so the head of the baby can pass. Muscle tone—Opposing sets of muscles are attached to bones to move joints in various directions. The tone of muscles—a mild basic level of contraction that protects joints and organs—is controlled by the nervous system. Neuromuscular problems can cause loss of muscle tone, increasing the range of movement possible and removing the muscles' protection of the joint. Lack of exercise also weakens the muscles that support and anchor highly flexible joints such as the shoulder, hip, wrist, and ankle.
=== Initiation === Before considering the propagation of action potentials along axons and their termination at the synaptic knobs, it is helpful to consider the methods by which action potentials can be initiated at the axon hillock. The basic requirement is that the membrane voltage at the hillock be raised above the threshold for firing. There are several ways in which this depolarization can occur.
=== COVID-19 pandemic === On 20 January 2020, Xi commented for the first time on the emerging COVID-19 pandemic in Wuhan, and ordered "efforts to curb the spread" of the virus. He gave premier Li Keqiang some responsibility over the COVID-19 response, in what has been suggested by The Wall Street Journal was an attempt to potentially insulate himself from criticism if the response failed. The government initially responded to the pandemic with a lockdown and censorship, with the initial response causing widespread backlash within China. Xi met with Tedros Adhanom Ghebreyesus, the director-general of the World Health Organization (WHO), on 28 January. Der Spiegel reported that in January 2020 Xi pressured Tedros Adhanom to hold off on issuing a global warning about the outbreak of COVID-19 and hold back information on human-to-human transmission of the virus, allegations denied by the WHO. On 5 February, Xi met with Cambodian prime minister Hun Sen in Beijing, the first foreign leader allowed into China since the outbreak. After the COVID-19 outbreak got under control in Wuhan, Xi visited the city on 10 March. After getting the outbreak in Wuhan under control, Xi has favoured what has officially been termed "dynamic zero-COVID policy" that aims to control and suppress the virus as much as possible within the country's borders. This has involved local lockdowns and mass-testing.
Sources: en.wikipedia.org
Aside from its acute effects, BRD-6929 was not well-tolerated and compromised health with chronic administration for 10 days in rodents, whereas no health compromise was observed with chronic administration of vorinostat. On the other hand, in another study, BRD-6929 produced longevity-enhancing effects in rodents in multiple organ systems, including the kidney, brain, and heart. BRD-6929 has been found to rescue chlorpyrifos-induced social deficits in zebrafish similarly to butyric acid (butyrate).
Two adults and five children at the Kindercare kindergarten in Christchurch suffer chemical burns after being accidentally exposed to a hazardous substance being poured on a waterslide. The Controller and Auditor-General of New Zealand launches an investigation into the Chatham Islands Council's expenditure and procurement policies. Craig Stobo temporarily steps down as chairperson of the Financial Market Authority pending an investigation by the Ministry of Business, Innovation and Employment (MBIE). 6 December — A measles case is reported in Queenstown, bringing the total number of cases reported nationally to 30. 22 cases are no longer infectious. 8 December: A wildfire engulfs over 320 hectares of Tongariro National Park, leading to the closure of sections of State Highway 47. Significant firefighting resources including 60 firefighters, 16 vehicles and nine helicopters are deployed to contain the blaze. The National Iwi Chairs Forum delivers a 24,000-strong petition urging the Education Minister Erica Stanford to reverse an amendment abolishing the requirement for school boards to uphold the Treaty of Waitangi. 9 December: The Supreme Court of New Zealand rules that two parents who care for their severely disabled adult children should be recognised as homeworkers who are entitled to the minimum wage. The New Zealand Government announces two proposed bills to replace the Resource Management Act 1991.
On the other hand, if the starting material is enough to develop more complete protocol, the amount of work to reach the separation goal depends on the available sample information and target molecule properties. Limits to development of purification protocols many times depends on the source of the substance to be purified, whether from natural sources (harvested tissues or organisms, for example), recombinant sources (such as using prokaryotic or eukaryotic vectors in their respective expression systems), or totally synthetic sources. No chromatographic techniques provide 100% yield of active material and overall yields depend on the number of steps in the purification protocol. By optimizing each step for the intended purpose and arranging them that minimizes inter step treatments, the number of steps will be minimized. A typical multistep purification protocol starts with a preliminary capture step which often utilizes ion exchange chromatography (IEC). The media (stationary phase) resin consists of beads, which range in size from being large (good for fast flow rates and little to no sample clarification at the expense of resolution) to small (for best possible resolution with all other factors being equal). Short and wide column geometries are amenable to high flow rates also at the expense of resolution, typically because of lateral diffusion of sample on the column. For techniques such as size exclusion chromatography to be useful, very long, thin columns and minimal sample volumes (maximum 5% of column volume) are required.
To reduce radiation exposure, the American Society of Nuclear Cardiology (ASNC) issued dosage recommendations in 2010. The effective dose is 2.4 mSv for 13N-ammonia, 2.5 mSv for 15O-water, 7 mSv for 18F-fluorodeoxyglucose, and 13.5 mSv for 82Rb-rubidium chloride. Compliance with these recommendations is expected to reduce the average radiation exposure to = 9 mSv. The Ordinance on Radioactive Drugs or Drugs Treated with Ionizing Radiation § 2 AMRadV (in German) regulates the approval procedures for the marketability of radioactive drugs.
=== Addison's Disease === Corticotropic cells can also be the cause of Addison's disease in some instances. Addison's disease is characterized adrenal insufficiency, which is defined as the underproduction of glucocorticoids by the adrenal cortex. If the corticotropes underproduce ACTH this can result in secondary adrenal insufficiency, causing the adrenal glands to underproduce cortisol. This can be caused by tumors of the anterior pituitary or hypothalamus, inflammation, or surgery. This ultimately results in the underproduction of cortisol, which has many detrimental symptoms. Symptoms of Addison's disease include:
Sources: en.wikipedia.org
Aqueous NAD+ solutions are best kept frozen in aliquots and protected from light. Repeated freezing and thawing is avoided because it can accelerate breakdown. Dry powder stored desiccated at -20 °C or lower typically remains stable for longer periods.
Liquid chromatography-mass spectrometry provides sensitive and specific quantification in cells and tissues. Enzymatic cycling assays are also widely used for plate-based measurement. Both methods need rapid sample processing to prevent post-collection changes.
Purity refers to the proportion of the intended dinucleotide relative to related nucleotides, salts, and water. A high-purity grade supports reproducible enzymatic assays. Researchers often check purity by chromatographic and spectroscopic methods before use.
NAD+ is an oxidized dinucleotide coenzyme that carries electrons in metabolic reactions. It is also consumed by signaling enzymes, including sirtuins and PARPs. Its reduced form is NADH.